Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Vaxart Inc (VXRT)

NASDAQ
Currency in USD
Disclaimer
0.6950
+0.0366(+5.56%)
Real-time Data

VXRT Comments

Vaxart urgently needs to communicate the Phase 1 results intelligibly by independent experts so that the average investor can understand and calm down. The PR was D-.
with= between
There is much in common between this and  summer premarket massacre.
I'm not an expert but from my gambling experience they are willing to keep this trade at 9.3 today , just to make costumers happy , then drop it to 8.65 by next monday , drop it then 8.4 next day then 9.3 , then 7.7 on thursday then 7.1 or something. i downloaded their reports for the pill and i don't see a negative reaction or negative effects, but if this company is not a scam then after they complete 1st phase( which who knows when it is ) , the stock will max go to 17-19 , which is good. then depend how the *biggs* play the game again.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.